{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:10:31Z","timestamp":1754154631553,"version":"3.41.2"},"publisher-location":"Cham","reference-count":123,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031993732"},{"type":"electronic","value":"9783031993749"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/16833_2024_368","type":"book-chapter","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:12:21Z","timestamp":1725941541000},"page":"227-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Innate Lymphoid Cells in Cancer: Immunobiology and Immunotherapy"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-7084","authenticated-orcid":false,"given":"Luana Madalena","family":"Sousa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5641-6975","authenticated-orcid":false,"given":"Jos\u00e9 Guilherme","family":"Tralh\u00e3o","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-8061","authenticated-orcid":false,"given":"Manuela","family":"Ferreira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-1620","authenticated-orcid":false,"given":"Paulo","family":"Rodrigues-Santos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"issue":"2","key":"368_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","volume":"40","author":"A Alam","year":"2022","unstructured":"Alam A, Levanduski E, Denz P, Villavicencio HS, Bhatta M, Alhorebi L, Zhang Y, Gomez EC, Morreale B, Senchanthisai S, Li J, Turowski SG, Sexton S, Sait SJ, Singh PK, Wang J, Maitra A, Kalinski P, DePinho RA et al (2022) Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer. Cancer Cell 40(2):153\u2013167.e11. https:\/\/doi.org\/10.1016\/j.ccell.2022.01.003","journal-title":"Cancer Cell"},{"issue":"6","key":"368_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","volume":"17","author":"SM Bal","year":"2016","unstructured":"Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P, Bruchard M, Villaudy J, Munneke JM, Fokkens W, Erjef\u00e4lt JS, Spits H, Ros XR (2016) IL-1\u03b2, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17(6):636\u2013645. https:\/\/doi.org\/10.1038\/ni.3444","journal-title":"Nat Immunol"},{"issue":"9","key":"368_CR3","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","volume":"20","author":"SM Bal","year":"2020","unstructured":"Bal SM, Golebski K, Spits H (2020) Plasticity of innate lymphoid cell subsets. Nat Rev Immunol 20(9):552\u2013565. https:\/\/doi.org\/10.1038\/s41577-020-0282-9","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"368_CR4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1146\/annurev-physiol-020518-114630","volume":"81","author":"JL Barlow","year":"2019","unstructured":"Barlow JL, McKenzie ANJ (2019) Innate lymphoid cells of the lung. Annu Rev Physiol 81(1):429\u2013452. https:\/\/doi.org\/10.1146\/annurev-physiol-020518-114630","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"368_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, Munneke JM, Hazenberg MD, Villaudy J, Buskens CJ, Bemelman WA, Diefenbach A, Blom B, Spits H (2015) Interleukin-12 and -23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43(1):146\u2013160. https:\/\/doi.org\/10.1016\/j.immuni.2015.06.019","journal-title":"Immunity"},{"issue":"8","key":"368_CR6","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41590-019-0423-0","volume":"20","author":"JH Bernink","year":"2019","unstructured":"Bernink JH, Ohne Y, Teunissen MBM, Wang J, Wu J, Krabbendam L, Guntermann C, Volckmann R, Koster J, van Tol S, Ramirez I, Shrestha Y, de Rie MA, Spits H, Romero RX, Humbles AA (2019) c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies. Nat Immunol 20(8):992\u20131003. https:\/\/doi.org\/10.1038\/s41590-019-0423-0","journal-title":"Nat Immunol"},{"key":"368_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/923135","volume":"2014","author":"Q Bie","year":"2014","unstructured":"Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, Yang H, Chen D, Wang S, Xu H (2014) Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer. J Immunol Res 2014:923135. https:\/\/doi.org\/10.1155\/2014\/923135","journal-title":"J Immunol Res"},{"key":"368_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2022.101654","volume":"61\u201364","author":"M Bruchard","year":"2022","unstructured":"Bruchard M, Spits H (2022) The role of ILC subsets in cancer. Semin Immunol 61\u201364:101654. https:\/\/doi.org\/10.1016\/j.smim.2022.101654","journal-title":"Semin Immunol"},{"issue":"12","key":"368_CR9","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1016\/j.jid.2016.07.017","volume":"136","author":"MC Br\u00fcggen","year":"2016","unstructured":"Br\u00fcggen MC, Bauer WM, Reininger B, Clim E, Captarencu C, Steiner GE, Brunner PM, Meier B, French LE, Stingl G (2016) In situ mapping of innate lymphoid cells in human skin: evidence for remarkable differences between normal and inflamed skin. J Invest Dermatol 136(12):2396\u20132405. https:\/\/doi.org\/10.1016\/j.jid.2016.07.017","journal-title":"J Invest Dermatol"},{"issue":"20","key":"368_CR10","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1182\/blood-2010-11-318956","volume":"117","author":"S Carotta","year":"2011","unstructured":"Carotta S, Pang SHM, Nutt SL, Belz GT (2011) Identification of the earliest NK-cell precursor in the mouse BM. Blood 117(20):5449\u20135452. https:\/\/doi.org\/10.1182\/blood-2010-11-318956","journal-title":"Blood"},{"issue":"1","key":"368_CR11","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.1038\/ncomms9280","volume":"6","author":"P Carrega","year":"2015","unstructured":"Carrega P, Loiacono F, Di Carlo E, Scaramuccia A, Mora M, Conte R, Benelli R, Spaggiari GM, Cantoni C, Campana S, Bonaccorsi I, Morandi B, Truini M, Mingari MC, Moretta L, Ferlazzo G (2015) NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun 6(1):8280. https:\/\/doi.org\/10.1038\/ncomms9280","journal-title":"Nat Commun"},{"issue":"24","key":"368_CR12","doi-asserted-by":"publisher","first-page":"10961","DOI":"10.1073\/pnas.1005641107","volume":"107","author":"M Cella","year":"2010","unstructured":"Cella M, Otero K, Colonna M (2010) Expansion of human NK-22 cells with IL-7, IL-2, and IL-1\u03b2 reveals intrinsic functional plasticity. Proc Natl Acad Sci USA 107(24):10961\u201310966. https:\/\/doi.org\/10.1073\/pnas.1005641107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"368_CR13","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41590-019-0425-y","volume":"20","author":"M Cella","year":"2019","unstructured":"Cella M, Gamini R, S\u00e9cca C, Collins PL, Zhao S, Peng V, Robinette ML, Schettini J, Zaitsev K, Gordon W, Bando JK, Yomogida K, Cortez V, Fronick C, Fulton R, Lin LL, Gilfillan S, Flavell RA, Shan L et al (2019) Subsets of ILC3\u2212ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues. Nat Immunol 20(8):980\u2013991. https:\/\/doi.org\/10.1038\/s41590-019-0425-y","journal-title":"Nat Immunol"},{"issue":"4","key":"368_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/mi.2013.101","volume":"7","author":"IH Chan","year":"2014","unstructured":"Chan IH, Jain R, Tessmer MS, Gorman D, Mangadu R, Sathe M, Vives F, Moon C, Penaflor E, Turner S, Ayanoglu G, Chang C, Basham B, Mumm JB, Pierce RH, Yearley JH, McClanahan TK, Phillips JH, Cua DJ et al (2014) Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells. Mucosal Immunol 7(4):842\u2013856. https:\/\/doi.org\/10.1038\/mi.2013.101","journal-title":"Mucosal Immunol"},{"issue":"6","key":"368_CR15","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.immuni.2018.05.010","volume":"48","author":"DE Cherrier","year":"2018","unstructured":"Cherrier DE, Serafini N, Di Santo JP (2018) Innate lymphoid cell development: a T cell perspective. Immunity 48(6):1091\u20131103. https:\/\/doi.org\/10.1016\/j.immuni.2018.05.010","journal-title":"Immunity"},{"issue":"8","key":"368_CR16","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1172\/JCI89717","volume":"127","author":"MF Chevalier","year":"2017","unstructured":"Chevalier MF, Trabanelli S, Racle J, Salom\u00e9 B, Cesson V, Gharbi D, Bohner P, Domingos-Pereira S, Dartiguenave F, Fritschi AS, Speiser DE, Rentsch CA, Gfeller D, Jichlinski P, Nardelli-Haefliger D, Jandus C, Derr\u00e9 L (2017) ILC2-modulated T cell\u2013to-MDSC balance is associated with bladder cancer recurrence. J Clin Invest 127(8):2916\u20132929. https:\/\/doi.org\/10.1172\/JCI89717","journal-title":"J Clin Invest"},{"issue":"5","key":"368_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.immuni.2016.03.007","volume":"44","author":"VS Cortez","year":"2016","unstructured":"Cortez VS, Cervantes-Barragan L, Robinette ML, Bando JK, Wang Y, Geiger TL, Gilfillan S, Fuchs A, Vivier E, Sun JC, Cella M, Colonna M (2016) Transforming growth factor-\u03b2 signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44(5):1127\u20131139. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.007","journal-title":"Immunity"},{"issue":"9","key":"368_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ni.3809","volume":"18","author":"VS Cortez","year":"2017","unstructured":"Cortez VS, Ulland TK, Cervantes-Barragan L, Bando JK, Robinette ML, Wang Q, White AJ, Gilfillan S, Cella M, Colonna M (2017) SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-\u03b2 signaling. Nat Immunol 18(9):995\u20131003. https:\/\/doi.org\/10.1038\/ni.3809","journal-title":"Nat Immunol"},{"issue":"1","key":"368_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","volume":"11","author":"B C\u00f3zar","year":"2021","unstructured":"C\u00f3zar B, Greppi M, Carpentier S, Narni-Mancinelli E, Chiossone L, Vivier E (2021) Tumor-infiltrating natural killer cells. Cancer Discov 11(1):34\u201344. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0655","journal-title":"Cancer Discov"},{"issue":"3","key":"368_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cell.2016.01.002","volume":"164","author":"S Dadi","year":"2016","unstructured":"Dadi S, Chhangawala S, Whitlock BM, Franklin RA, Luo CT, Oh SA, Toure A, Pritykin Y, Huse M, Leslie CS, Li MO (2016) Cancer Immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells. Cell 164(3):365\u2013377. https:\/\/doi.org\/10.1016\/j.cell.2016.01.002","journal-title":"Cell"},{"issue":"1","key":"368_CR21","doi-asserted-by":"publisher","first-page":"12233","DOI":"10.1038\/s41598-021-91500-z","volume":"11","author":"P de Luc\u00eda Finkel","year":"2021","unstructured":"de Luc\u00eda Finkel P, Sherwood C, Saranchova I, Xia W, Munro L, Pfeifer CG et al (2021) Serum free culture for the expansion and study of type 2 innate lymphoid cells. Sci Rep 11(1):12233. https:\/\/doi.org\/10.1038\/s41598-021-91500-z","journal-title":"Sci Rep"},{"issue":"11","key":"368_CR22","doi-asserted-by":"publisher","first-page":"e461","DOI":"10.3324\/haematol.2016.144725","volume":"101","author":"I de Weerdt","year":"2016","unstructured":"de Weerdt I, van Hoeven V, Munneke JM, Endstra S, Hofland T, Hazenberg MD, Kater AP (2016) Innate lymphoid cells are expanded and functionally altered in chronic lymphocytic leukemia. Haematologica 101(11):e461\u2013e464. https:\/\/doi.org\/10.3324\/haematol.2016.144725","journal-title":"Haematologica"},{"issue":"11","key":"368_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fimmu.2020.00802","volume":"5","author":"Y Deng","year":"2020","unstructured":"Deng Y, Wu S, Yang Y, Meng M, Chen X, Chen S, Li L, Gao Y, Cai Y, Imani S, Chen B, Li S, Deng Y, Li X (2020) Unique phenotypes of heart resident type 2 innate lymphoid cells. Front Immunol 5(11):802. https:\/\/doi.org\/10.3389\/fimmu.2020.00802","journal-title":"Front Immunol"},{"issue":"47","key":"368_CR24","doi-asserted-by":"publisher","first-page":"81729","DOI":"10.18632\/oncotarget.21046","volume":"8","author":"JP Di Santo","year":"2017","unstructured":"Di Santo JP, Lim AI, Yssel H (2017) \u2018ILC-poiesis\u2019: generating tissue ILCs from na\u00efve precursors. Oncotarget 8(47):81729\u201381730. https:\/\/doi.org\/10.18632\/oncotarget.21046","journal-title":"Oncotarget"},{"issue":"27","key":"368_CR25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2026271118","volume":"118","author":"L Ducimeti\u00e8re","year":"2021","unstructured":"Ducimeti\u00e8re L, Lucchiari G, Litscher G, Nater M, Heeb L, Nu\u00f1ez NG, Wyss L, Burri D, Vermeer M, Gschwend J, Moor AE, Becher B, van den Broek M, Tugues S (2021) Conventional NK cells and tissue-resident ILC1s join forces to control liver metastasis. Proc Natl Acad Sci USA 118(27):e2026271118. https:\/\/doi.org\/10.1073\/pnas.2026271118","journal-title":"Proc Natl Acad Sci USA"},{"issue":"35","key":"368_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau8082","volume":"4","author":"EE Dutton","year":"2019","unstructured":"Dutton EE, Gajdasik DW, Willis C, Fiancette R, Bishop EL, Camelo A, Sleeman MA, Coccia M, Didierlaurent AM, Tomura M, Pilataxi F, Morehouse CA, Carlesso G, Withers DR (2019) Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations. Sci Immunol 4(35):eaau8082. https:\/\/doi.org\/10.1126\/sciimmunol.aau8082","journal-title":"Sci Immunol"},{"issue":"4","key":"368_CR27","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1158\/2326-6066.CIR-19-0504","volume":"8","author":"G Ercolano","year":"2020","unstructured":"Ercolano G, Garcia-Garijo A, Salom\u00e9 B, Gomez-Cadena A, Vanoni G, Mastelic-Gavillet B, Ianaro A, Speiser DE, Romero P, Trabanelli S, Jandus C (2020) Immunosuppressive mediators impair Proinflammatory innate lymphoid cell function in human malignant melanoma. Cancer Immunol Res 8(4):556\u2013564. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0504","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"368_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.it.2010.06.004","volume":"31","author":"S Eyerich","year":"2010","unstructured":"Eyerich S, Eyerich K, Cavani A, Schmidt-Weber C (2010) IL-17 and IL-22: siblings, not twins. Trends Immunol 31(9):354\u2013361. https:\/\/doi.org\/10.1016\/j.it.2010.06.004","journal-title":"Trends Immunol"},{"issue":"6","key":"368_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/S1074-7613(01)00243-6","volume":"15","author":"MM Fort","year":"2001","unstructured":"Fort MM, Cheung J, Yen D, Li J, Zurawski SM, Lo S, Menon S, Clifford T, Hunte B, Lesley R, Muchamuel T, Hurst SD, Zurawski G, Leach MW, Gorman DM, Rennick DM (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15(6):985\u2013995. https:\/\/doi.org\/10.1016\/S1074-7613(01)00243-6","journal-title":"Immunity"},{"key":"368_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2020.101054","volume":"7","author":"M Frech","year":"2020","unstructured":"Frech M, Knipfer L, Wirtz S, Zaiss MM (2020) An in vivo gene delivery approach for the isola0on of reasonable numbers of type 2 innate lymphoid cells. MethodsX 7:101054. https:\/\/doi.org\/10.1016\/j.mex.2020.101054","journal-title":"MethodsX"},{"issue":"5","key":"368_CR31","first-page":"549","volume":"4","author":"E Friedman","year":"1995","unstructured":"Friedman E, Gold LI, Klimstra D, Zeng ZS, Winawer S, Cohen A (1995) High levels of transforming growth factor beta 1 correlate with disease progression in human colon cancer. Cancer Epidemiol Biomarkers Prev 4(5):549\u2013554","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"368_CR32","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-\u03b3-producing cells. Immunity 38(4):769\u2013781. https:\/\/doi.org\/10.1016\/j.immuni.2013.02.010","journal-title":"Immunity"},{"issue":"9","key":"368_CR33","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ni.3800","volume":"18","author":"Y Gao","year":"2017","unstructured":"Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT et al (2017) Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol 18(9):1004\u20131015. https:\/\/doi.org\/10.1038\/ni.3800","journal-title":"Nat Immunol"},{"issue":"5","key":"368_CR34","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.jaci.2021.03.009","volume":"147","author":"M Ghaedi","year":"2021","unstructured":"Ghaedi M, Takei F (2021) Innate lymphoid cell development. J Allergy Clin Immunol 147(5):1549\u20131560. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.009","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"368_CR35","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1016\/j.cell.2021.07.029","volume":"184","author":"J Goc","year":"2021","unstructured":"Goc J, Lv M, Bessman NJ, Flamar AL, Sahota S, Suzuki H, Teng F, Putzel GG, Eberl G, Withers DR, Arthur JC, Shah MA, Sonnenberg GF (2021) Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer. Cell 184(19):5015\u20135030.e16. https:\/\/doi.org\/10.1016\/j.cell.2021.07.029","journal-title":"Cell"},{"issue":"1","key":"368_CR36","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1038\/s41467-019-09883-7","volume":"10","author":"K Golebski","year":"2019","unstructured":"Golebski K, Ros XR, Nagasawa M, van Tol S, Heesters BA, Aglmous H, Kradolfer CMA, Shikhagaie MM, Seys S, Hellings PW, van Drunen CM, Fokkens WJ, Spits H, Bal SM (2019) IL-1\u03b2, IL-23, and TGF-\u03b2 drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation. Nat Commun 10(1):2162. https:\/\/doi.org\/10.1038\/s41467-019-09883-7","journal-title":"Nat Commun"},{"issue":"1","key":"368_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/imcb.12390","volume":"99","author":"C Guillerey","year":"2021","unstructured":"Guillerey C, Stannard K, Chen J, Krumeich S, Miles K, Nakamura K, Smith J, Yu Y, Ng S, Harjunp\u00e4\u00e4 H, Teng MW, Engwerda C, Belz GT, Smyth MJ (2021) Systemic administration of IL-33 induces a population of circulating KLRG1hi type 2 innate lymphoid cells and inhibits type 1 innate immunity against multiple myeloma. Immunol Cell Biol 99(1):65\u201383. https:\/\/doi.org\/10.1111\/imcb.12390","journal-title":"Immunol Cell Biol"},{"key":"368_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4939-3603-8-18","volume":"1422","author":"X Guo","year":"2016","unstructured":"Guo X, Muite K, Wroblewska J, Fu Y-X (2016) Purification and adoptive transfer of group 3 gut innate lymphoid cells. Methods Mol Biol 1422:189\u2013196. https:\/\/doi.org\/10.1007\/978-1-4939-3603-8-18","journal-title":"Methods Mol Biol"},{"key":"368_CR39","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1158\/1538-7445.AM2022-5185","volume":"82","author":"K Harano","year":"2022","unstructured":"Harano K, Kaneko S, Nakatsura T, Yuda J, Fuse N, Sato A, Watanabe R, Ishii G, Mukohara T, Tanabe H, Ishiguro Y, Furuya H, Wakabayashi M, Fukutani M, Shimomura M, Ueda T, Iriguchi S, Kumagai A, Nakagoshi K, Sasaki A, Doi T (2022) Abstract 5185: first in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination. Cancer Res 82:5185. https:\/\/doi.org\/10.1158\/1538-7445.AM2022-5185","journal-title":"Cancer Res"},{"issue":"6","key":"368_CR40","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/gutjnl-2021-325288","volume":"71","author":"B Heinrich","year":"2022","unstructured":"Heinrich B, Gertz EM, Sch\u00e4ffer AA, Craig A, Ruf B, Subramanyam V, McVey JC, Diggs LP, Heinrich S, Rosato U, Ma C, Yan C, Hu Y, Zhao Y, Shen TW, Kapoor V, Telford W, Kleiner DE, Stovroff MK et al (2022) The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma. Gut 71(6):1161\u20131175. https:\/\/doi.org\/10.1136\/gutjnl-2021-325288","journal-title":"Gut"},{"issue":"7452","key":"368_CR41","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","volume":"498","author":"MR Hepworth","year":"2013","unstructured":"Hepworth MR, Monticelli LA, Fung TC, Ziegler CGK, Grunberg S, Sinha R, Mantegazza AR, Ma HL, Crawford A, Angelosanto JM, Wherry EJ, Koni PA, Bushman FD, Elson CO, Eberl G, Artis D, Sonnenberg GF (2013) Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498(7452):113\u2013117. https:\/\/doi.org\/10.1038\/nature12240","journal-title":"Nature"},{"issue":"10","key":"368_CR42","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1016\/j.immuni.2021.07.019","volume":"54","author":"DC Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez DC, Juelke K, M\u00fcller NC, Durek P, Ugursu B, Mashreghi MF, R\u00fcckert T, Romagnani C (2021) An in vitro platform supports generation of human innate lymphoid cells from CD34+ hematopoietic progenitors that recapitulate ex vivo identity. Immunity 54(10):2417\u20132432.e5. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.019","journal-title":"Immunity"},{"issue":"3","key":"368_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/cancers13030559","volume":"13","author":"Q Huang","year":"2021","unstructured":"Huang Q, Jacquelot N, Preaudet A, Hediyeh-zadeh S, Souza-Fonseca-Guimaraes F, McKenzie ANJ, Hansbro PM, Davis MJ, Mielke LA, Putoczki TL, Belz GT (2021) Type 2 innate lymphoid cells protect against colorectal cancer progression and predict improved patient survival. Cancers 13(3):559. https:\/\/doi.org\/10.3390\/cancers13030559","journal-title":"Cancers"},{"issue":"6","key":"368_CR44","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1158\/2326-6066.CIR-19-0775","volume":"8","author":"A Ikeda","year":"2020","unstructured":"Ikeda A, Ogino T, Kayama H, Okuzaki D, Nishimura J, Fujino S, Miyoshi N, Takahashi H, Uemura M, Matsuda C, Yamamoto H, Takeda K, Mizushima T, Mori M, Doki Y (2020) Human NKp44+ group 3 innate lymphoid cells associate with tumor-associated tertiary lymphoid structures in colorectal cancer. Cancer Immunol Res 8(6):724\u2013731. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0775","journal-title":"Cancer Immunol Res"},{"issue":"2","key":"368_CR45","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4049\/jimmunol.1101270","volume":"188","author":"M Ikutani","year":"2012","unstructured":"Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, Kouro T, Itakura A, Nagai Y, Takaki S, Takatsu K (2012) Identification of innate IL-5\u2013producing cells and their role in lung eosinophil regulation and antitumor immunity. J Immunol 188(2):703\u2013713. https:\/\/doi.org\/10.4049\/jimmunol.1101270","journal-title":"J Immunol"},{"issue":"5","key":"368_CR46","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1158\/0008-5472.CAN-16-0598","volume":"77","author":"S Irshad","year":"2017","unstructured":"Irshad S, Flores-Borja F, Lawler K, Monypenny J, Evans R, Male V, Gordon P, Cheung A, Gazinska P, Noor F, Wong F, Grigoriadis A, Fruhwirth GO, Barber PR, Woodman N, Patel D, Rodriguez-Justo M, Owen J, Martin SG, Ng T (2017) ROR\u03b3t+ innate lymphoid cells promote lymph node metastasis of breast cancers. Cancer Res 77(5):1083\u20131096. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0598","journal-title":"Cancer Res"},{"issue":"7","key":"368_CR47","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41590-021-00943-z","volume":"22","author":"N Jacquelot","year":"2021","unstructured":"Jacquelot N, Seillet C, Wang M, Pizzolla A, Liao Y, Hediyeh-zadeh S, Grisaru-Tal S, Louis C, Huang Q, Schreuder J, Souza-Fonseca-Guimaraes F, de Graaf CA, Thia K, Macdonald S, Camilleri M, Luong K, Zhang S, Chopin M, Molden-Hauer T, Belz GT (2021) Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma. Nat Immunol 22(7):851\u2013864. https:\/\/doi.org\/10.1038\/s41590-021-00943-z","journal-title":"Nat Immunol"},{"issue":"12","key":"368_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188649","volume":"12","author":"HC Jeffery","year":"2017","unstructured":"Jeffery HC, McDowell P, Lutz P, Wawman RE, Roberts S, Bagnall C, Birtwistle J, Adams DH, Oo YH (2017) Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS One 12(12):e0188649. https:\/\/doi.org\/10.1371\/journal.pone.0188649","journal-title":"PLoS One"},{"issue":"6","key":"368_CR49","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41590-022-01213-2","volume":"23","author":"ER Kansler","year":"2022","unstructured":"Kansler ER, Dadi S, Krishna C, Nixon BG, Stamatiades EG, Liu M, Kuo F, Zhang J, Zhang X, Capistrano K, Blum KA, Weiss K, Kedl RM, Cui G, Ikuta K, Chan TA, Leslie CS, Hakimi AA, Li MO (2022) Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignancies. Nat Immunol 23(6):904\u2013915. https:\/\/doi.org\/10.1038\/s41590-022-01213-2","journal-title":"Nat Immunol"},{"issue":"2","key":"368_CR50","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/eji.1830050209","volume":"5","author":"R Kiessling","year":"1975","unstructured":"Kiessling R, Klein E, Pross H, Wigzell H (1975) \u201cNatural\u201d killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol 5(2):117\u2013121. https:\/\/doi.org\/10.1002\/eji.1830050209","journal-title":"Eur J Immunol"},{"issue":"170","key":"368_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005374","volume":"5","author":"BS Kim","year":"2013","unstructured":"Kim BS, Siracusa MC, Saenz SA, Noti M, Monticelli LA, Sonnenberg GF, Hepworth MR, Van Voorhees AS, Comeau MR, Artis D (2013) TSLP elicits IL-33\u2013independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 5(170):170ra16. https:\/\/doi.org\/10.1126\/scitranslmed.3005374","journal-title":"Sci Transl Med"},{"issue":"5","key":"368_CR52","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.4049\/jimmunol.1501730","volume":"196","author":"J Kim","year":"2016","unstructured":"Kim J, Kim W, Moon UJ, Kim HJ, Choi HJ, Sin JI, Park NH, Cho HR, Kwon B (2016) Intratumorally establishing type 2 innate lymphoid cells blocks tumor growth. J Immunol 196(5):2410\u20132423. https:\/\/doi.org\/10.4049\/jimmunol.1501730","journal-title":"J Immunol"},{"issue":"25","key":"368_CR53","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1182\/bloodadvances.2017012732","volume":"1","author":"J Kini Bailur","year":"2017","unstructured":"Kini Bailur J, Mehta S, Zhang L, Neparidze N, Parker T, Bar N, Anderson T, Xu ML, Dhodapkar KM et al (2017) Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv 1(25):2343\u20132347. https:\/\/doi.org\/10.1182\/bloodadvances.2017012732","journal-title":"Blood Adv"},{"issue":"5","key":"368_CR54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1084\/jem.20122308","volume":"210","author":"S Kirchberger","year":"2013","unstructured":"Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, Harrison O, Powrie F (2013) Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210(5):917\u2013931. https:\/\/doi.org\/10.1084\/jem.20122308","journal-title":"J Exp Med"},{"issue":"2","key":"368_CR55","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2014.03.030","volume":"157","author":"CSN Klose","year":"2014","unstructured":"Klose CSN, Flach M, M\u00f6hle L, Rogell L, Hoyler T, Ebert K, Fabiunke C, Pfeifer D, Sexl V, Fonseca-Pereira D, Domingues RG, Veiga-Fernandes H, Arnold SJ, Busslinger M, Dunay IR, Tanriver Y, Diefenbach A (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157(2):340\u2013356. https:\/\/doi.org\/10.1016\/j.cell.2014.03.030","journal-title":"Cell"},{"issue":"13","key":"368_CR56","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1158\/1078-0432.CCR-18-3458","volume":"25","author":"J Koh","year":"2019","unstructured":"Koh J, Kim HY, Lee Y, Park IK, Kang CH, Kim YT, Kim JE, Choi M, Lee WW, Jeon YK, Chung DH (2019) IL23-producing human lung cancer cells promote tumor growth via conversion of innate lymphoid cell 1 (ILC1) into ILC3. Clin Cancer Res 25(13):4026\u20134037. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-3458","journal-title":"Clin Cancer Res"},{"issue":"5","key":"368_CR57","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0092-8674(00)80453-5","volume":"91","author":"M Kondo","year":"1997","unstructured":"Kondo M, Weissman IL, Akashi K (1997) Identification of Clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91(5):661\u2013672. https:\/\/doi.org\/10.1016\/S0092-8674(00)80453-5","journal-title":"Cell"},{"issue":"4","key":"368_CR58","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/eji.202048696","volume":"51","author":"L Krabbendam","year":"2021","unstructured":"Krabbendam L, Heesters BA, Kradolfer CMA, Spits H, Bernink JH (2021) Identification of human cytotoxic ILC3s. Eur J Immunol 51(4):811\u2013823. https:\/\/doi.org\/10.1002\/eji.202048696","journal-title":"Eur J Immunol"},{"issue":"7101","key":"368_CR59","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature04808","volume":"442","author":"JL Langowski","year":"2006","unstructured":"Langowski JL, Zhang X, Wu L, Mattson JD, Chen T, Smith K, Basham B, McClanahan T, Kastelein RA, Oft M (2006) IL-23 promotes tumour incidence and growth. Nature 442(7101):461\u2013465. https:\/\/doi.org\/10.1038\/nature04808","journal-title":"Nature"},{"issue":"5","key":"368_CR60","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41590-022-01198-y","volume":"23","author":"Z Li","year":"2022","unstructured":"Li Z, Ma R, Ma S, Tian L, Lu T, Zhang J, Mundy-Bosse BL, Zhang B, Marcucci G, Caligiuri MA, Yu J (2022) ILC1s control leukemia stem cell fate and limit development of AML. Nat Immunol 23(5):718\u2013730. https:\/\/doi.org\/10.1038\/s41590-022-01198-y","journal-title":"Nat Immunol"},{"issue":"3","key":"368_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112241","volume":"42","author":"S Li","year":"2023","unstructured":"Li S, Wang CS, Montel-Hagen A et al (2023) Strength of CAR signaling determines T cell versus ILC differentiation from pluripotent stem cells. Cell Rep 42(3):112241. https:\/\/doi.org\/10.1016\/j.celrep.2023.112241","journal-title":"Cell Rep"},{"issue":"1","key":"368_CR62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/eji.201747294","volume":"49","author":"AI Lim","year":"2019","unstructured":"Lim AI, Di Santo JP (2019) ILC-poiesis: ensuring tissue ILC differentiation at the right place and time. Eur J Immunol 49(1):11\u201318. https:\/\/doi.org\/10.1002\/eji.201747294","journal-title":"Eur J Immunol"},{"issue":"6","key":"368_CR63","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.cell.2017.02.021","volume":"168","author":"AI Lim","year":"2017","unstructured":"Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, Masse-Ranson G, David E, Strick-Marchand H, Le Bourhis L, Cocchi R, Topazio D, Graziano P, Muscarella LA, Rogge L, Di Santo JP (2017) Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 168(6):1086\u20131100e10. https:\/\/doi.org\/10.1016\/j.cell.2017.02.021","journal-title":"Cell"},{"key":"368_CR64","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ebiom.2019.02.050","volume":"41","author":"Y Liu","year":"2019","unstructured":"Liu Y, Song Y, Lin D, Lei L, Mei Y, Jin Z, Gong H, Zhu Y, Hu B, Zhang Y, Zhao L, Teo HY, Qiu J, Jiang W, Dong C, Wu D, Huang Y, Liu H (2019) NCR\u2212 group 3 innate lymphoid cells orchestrate IL-23\/IL-17 axis to promote hepatocellular carcinoma development. EBioMedicine 41:333\u2013344. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.050","journal-title":"EBioMedicine"},{"issue":"11","key":"368_CR65","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.4049\/jimmunol.1800173","volume":"201","author":"A Long","year":"2018","unstructured":"Long A, Dominguez D, Qin L, Chen S, Fan J, Zhang M, Fang D, Zhang Y, Kuzel TM, Zhang B (2018) Type 2 innate lymphoid cells impede IL-33\u2013mediated tumor suppression. J Immunol 201(11):3456\u20133464. https:\/\/doi.org\/10.4049\/jimmunol.1800173","journal-title":"J Immunol"},{"issue":"1","key":"368_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1084\/jem.167.1.219","volume":"167","author":"AF Lopez","year":"1988","unstructured":"Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 167(1):219\u2013224. https:\/\/doi.org\/10.1084\/jem.167.1.219","journal-title":"J Exp Med"},{"key":"368_CR67","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3389\/fimmu.2019.02121","volume":"10","author":"R Loyon","year":"2019","unstructured":"Loyon R, Jary M, Salom\u00e9 B, Gomez-Cadena A, Galaine J, Kroemer M, Romero P, Trabanelli S, Adot\u00e9vi O, Borg C, Jandus C (2019) Peripheral innate lymphoid cells are increased in first line metastatic colorectal carcinoma patients: a negative correlation with Th1 immune responses. Front Immunol 10:2121. https:\/\/doi.org\/10.3389\/fimmu.2019.02121","journal-title":"Front Immunol"},{"issue":"4","key":"368_CR68","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1074-7613(00)80371-4","volume":"7","author":"RE Mebius","year":"1997","unstructured":"Mebius RE, Rennert P, Weissman IL (1997) Developing lymph nodes collect CD4 + CD3 \u2212 LT\u03b2 + cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7(4):493\u2013504. https:\/\/doi.org\/10.1016\/S1074-7613(00)80371-4","journal-title":"Immunity"},{"key":"368_CR69","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3389\/fimmu.2018.02396","volume":"9","author":"D Miller","year":"2018","unstructured":"Miller D, Motomura K, Garcia-Flores V, Romero R, Gomez-Lopez N (2018) Innate lymphoid cells in the maternal and fetal compartments. Front Immunol 9:2396. https:\/\/doi.org\/10.3389\/fimmu.2018.02396","journal-title":"Front Immunol"},{"issue":"6","key":"368_CR70","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.immuni.2014.11.010","volume":"41","author":"E Montaldo","year":"2014","unstructured":"Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, Babic M, Paclik D, St\u00f6lzel K, Gr\u00f6ne J, Lozza L, Juelke K, Matzmohr N, Loiacono F, Petronelli F, Huntington ND, Moretta L, Mingari MC, Romagnani C (2014) Human ROR\u03b3t+CD34+ cells are lineage-specified progenitors of group 3 ROR\u03b3t+ innate lymphoid cells. Immunity 41(6):988\u20131000. https:\/\/doi.org\/10.1016\/j.immuni.2014.11.010","journal-title":"Immunity"},{"issue":"7797","key":"368_CR71","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","volume":"579","author":"JA Moral","year":"2020","unstructured":"Moral JA, Leung J, Rojas LA, Ruan J, Zhao J, Sethna Z, Ramnarain A, Gasmi B, Gururajan M, Redmond D, Askan G, Bhanot U, Elyada E, Park Y, Tuveson DA, G\u00f6nen M, Leach SD, Wolchok JD, DeMatteo RP et al (2020) ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity. Nature 579(7797):130\u2013135. https:\/\/doi.org\/10.1038\/s41586-020-2015-4","journal-title":"Nature"},{"issue":"28","key":"368_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2101169118","volume":"118","author":"UY Moreno-Nieves","year":"2021","unstructured":"Moreno-Nieves UY, Tay JK, Saumyaa S, Horowitz NB, Shin JH, Mohammad IA, Luca B, Mundy DC, Gulati GS, Bedi N, Chang S, Chen C, Kaplan MJ, Rosenthal EL, Holsinger FC, Divi V, Baik FM, Sirjani DB, Gentles AJ et al (2021) Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment. Proc Natl Acad Sci USA 118(28):e2101169118. https:\/\/doi.org\/10.1073\/pnas.2101169118","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7280","key":"368_CR73","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature08636","volume":"463","author":"K Moro","year":"2010","unstructured":"Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463(7280):540\u2013544. https:\/\/doi.org\/10.1038\/nature08636","journal-title":"Nature"},{"issue":"1","key":"368_CR74","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ni.3309","volume":"17","author":"K Moro","year":"2016","unstructured":"Moro K, Kabata H, Tanabe M, Koga S, Takeno N, Mochizuki M, Fukunaga K, Asano K, Betsuyaku T, Koyasu S (2016) Interferon and IL-27 antagonize the function of group 2 innate lymphoid cells and type 2 innate immune responses. Nat Immunol 17(1):76\u201386. https:\/\/doi.org\/10.1038\/ni.3309","journal-title":"Nat Immunol"},{"issue":"6178","key":"368_CR75","doi-asserted-by":"publisher","first-page":"1249288","DOI":"10.1126\/science.1249288","volume":"343","author":"A Mortha","year":"2014","unstructured":"Mortha A, Chudnovskiy A, Hashimoto D, Bogunovic M, Spencer SP, Belkaid Y, Merad M (2014) Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343(6178):1249288. https:\/\/doi.org\/10.1126\/science.1249288","journal-title":"Science"},{"key":"368_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836999","volume":"13","author":"JM Murphy","year":"2022","unstructured":"Murphy JM, Ngai L, Mortha A, Crome SQ (2022) Tissue-dependent adaptations and functions of innate lymphoid cells. Front Immunol 13:836999. https:\/\/doi.org\/10.3389\/fimmu.2022.836999","journal-title":"Front Immunol"},{"issue":"12","key":"368_CR77","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030304","volume":"10","author":"M Nagasawa","year":"2018","unstructured":"Nagasawa M, Spits H, Ros XR (2018) Innate lymphoid cells (ILCs): cytokine hubs regulating immunity and tissue homeostasis. Cold Spring Harb Perspect Biol 10(12):a030304. https:\/\/doi.org\/10.1101\/cshperspect.a030304","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"70","key":"368_CR78","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi8642","volume":"7","author":"BG Nixon","year":"2022","unstructured":"Nixon BG, Chou C, Krishna C, Dadi S, Michel AO, Cornish AE, Kansler ER, Do MH, Wang X, Capistrano KJ, Rudensky AY, Leslie CS, Li MO (2022) Cytotoxic granzyme C\u2013expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity. Sci Immunol 7(70):eabi8642. https:\/\/doi.org\/10.1126\/sciimmunol.abi8642","journal-title":"Sci Immunol"},{"issue":"5","key":"368_CR79","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mi.2008.26","volume":"1","author":"W Ouyang","year":"2008","unstructured":"Ouyang W, Valdez P (2008) IL-22 in mucosal immunity. Mucosal Immunol 1(5):335\u2013338. https:\/\/doi.org\/10.1038\/mi.2008.26","journal-title":"Mucosal Immunol"},{"issue":"1","key":"368_CR80","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191030","volume":"217","author":"ME Parker","year":"2020","unstructured":"Parker ME, Barrera A, Wheaton JD, Zuberbuehler MK, Allan DSJ, Carlyle JR, Reddy TE, Ciofani M (2020) c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program. J Exp Med 217(1):e20191030. https:\/\/doi.org\/10.1084\/jem.20191030","journal-title":"J Exp Med"},{"issue":"4","key":"368_CR81","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00281-018-0687-8","volume":"40","author":"HA Penny","year":"2018","unstructured":"Penny HA, Hodge SH, Hepworth MR (2018) Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. Semin Immunopathol 40(4):357\u2013370. https:\/\/doi.org\/10.1007\/s00281-018-0687-8","journal-title":"Semin Immunopathol"},{"issue":"4","key":"368_CR82","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1067\/mai.2001.118600","volume":"108","author":"SM Pope","year":"2001","unstructured":"Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME (2001) IL-13 induces eosinophil recruitment into the lung by an IL-5\u2013 and eotaxin-dependent mechanism. J Allergy Clin Immunol 108(4):594\u2013601. https:\/\/doi.org\/10.1067\/mai.2001.118600","journal-title":"J Allergy Clin Immunol"},{"issue":"25","key":"368_CR83","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1073\/pnas.1003988107","volume":"107","author":"AE Price","year":"2010","unstructured":"Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM (2010) Systemically dispersed innate IL-13\u2013expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107(25):11489\u201311494. https:\/\/doi.org\/10.1073\/pnas.1003988107","journal-title":"Proc Natl Acad Sci USA"},{"issue":"27","key":"368_CR84","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1182\/bloodadvances.2017008839","volume":"1","author":"A Raykova","year":"2017","unstructured":"Raykova A, Carrega P, Lehmann FM, Ivanek R, Landtwing V, Quast I, L\u00fcnemann JD, Finke D, Ferlazzo G, Chijioke O, M\u00fcnz C (2017) Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells. Blood Adv 1(27):2679\u20132691. https:\/\/doi.org\/10.1182\/bloodadvances.2017008839","journal-title":"Blood Adv"},{"issue":"1","key":"368_CR85","doi-asserted-by":"publisher","first-page":"336","DOI":"10.4049\/jimmunol.167.1.336","volume":"167","author":"PA Reche","year":"2001","unstructured":"Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, Zurawski SM, Johnston J, Liu YJ, Spits H, de Waal MR, Kastelein RA, Bazan JF (2001) Human thymic stromal lymphopoietin preferentially stimulates myeloid cells. J Immunol 167(1):336\u2013343. https:\/\/doi.org\/10.4049\/jimmunol.167.1.336","journal-title":"J Immunol"},{"issue":"2","key":"368_CR86","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.immuni.2015.07.011","volume":"43","author":"VM Renoux","year":"2015","unstructured":"Renoux VM, Zriwil A, Peitzsch C, Micha\u00eblsson J, Friberg D, Soneji S, Sitnicka E (2015) Identification of a human natural killer cell lineage-restricted progenitor in fetal and adult tissues. Immunity 43(2):394\u2013407. https:\/\/doi.org\/10.1016\/j.immuni.2015.07.011","journal-title":"Immunity"},{"issue":"6","key":"368_CR87","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/cancers13061446","volume":"13","author":"L Rethacker","year":"2021","unstructured":"Rethacker L, Roelens M, Bejar C, Maubec E, Moins-Teisserenc H, Caignard A (2021) Specific patterns of blood ILCs in metastatic melanoma patients and their modulations in response to immunotherapy. Cancers 13(6):1446. https:\/\/doi.org\/10.3390\/cancers13061446","journal-title":"Cancers"},{"issue":"6","key":"368_CR88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41568-023-00562-w","volume":"23","author":"B Ruf","year":"2023","unstructured":"Ruf B, Greten TF, Korangy F (2023) Innate lymphoid cells and innate-like T cells in cancer \u2014 at the crossroads of innate and adaptive immunity. Nat Rev Cancer 23(6):351\u2013371. https:\/\/doi.org\/10.1038\/s41568-023-00562-w","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"368_CR89","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12885-018-4262-4","volume":"18","author":"M Salimi","year":"2018","unstructured":"Salimi M, Wang R, Yao X, Li X, Wang X, Hu Y, Chang X, Fan P, Dong T, Ogg G (2018) Activated innate lymphoid cell populations accumulate in human tumour tissues. BMC Cancer 18(1):341. https:\/\/doi.org\/10.1186\/s12885-018-4262-4","journal-title":"BMC Cancer"},{"issue":"5","key":"368_CR90","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA (2005) IL-33, an Interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5):479\u2013490. https:\/\/doi.org\/10.1016\/j.immuni.2005.09.015","journal-title":"Immunity"},{"key":"368_CR91","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96:41\u2013101. https:\/\/doi.org\/10.1016\/S0065-2776(07)96002-2","journal-title":"Adv Immunol"},{"issue":"5","key":"368_CR92","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.immuni.2016.04.007","volume":"44","author":"SD Scoville","year":"2016","unstructured":"Scoville SD, Mundy-Bosse BL, Zhang MH, Chen L, Zhang X, Keller KA, Hughes T, Chen L, Cheng S, Bergin SM, Mao HC, McClory S, Yu J, Carson WE, Caligiuri MA, Freud AG (2016) A progenitor cell expressing transcription factor ROR\u03b3t generates all human innate lymphoid cell subsets. Immunity 44(5):1140\u20131150. https:\/\/doi.org\/10.1016\/j.immuni.2016.04.007","journal-title":"Immunity"},{"issue":"6","key":"368_CR93","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/ni.3168","volume":"16","author":"CR Seehus","year":"2015","unstructured":"Seehus CR, Aliahmad P, de la Torre B, Iliev ID, Spurka L, Funari VA, Kaye J (2015) The development of innate lymphoid cells requires TOX-dependent generation of a common innate lymphoid cell progenitor. Nat Immunol 16(6):599\u2013608. https:\/\/doi.org\/10.1038\/ni.3168","journal-title":"Nat Immunol"},{"issue":"7","key":"368_CR94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nri3855","volume":"15","author":"N Serafini","year":"2015","unstructured":"Serafini N, Vosshenrich CAJ, Di Santo JP (2015) Transcriptional regulation of innate lymphoid cell fate. Nat Rev Immunol 15(7):415\u2013428. https:\/\/doi.org\/10.1038\/nri3855","journal-title":"Nat Rev Immunol"},{"key":"368_CR95","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.742571","volume":"13","author":"JJ Siegler","year":"2022","unstructured":"Siegler JJ, Correia MP, Hofman T, Prager I, Birgin E, Rahbari NN, Watzl C, Stojanovic A, Cerwenka A (2022) Human ILC3 exert TRAIL-mediated cytotoxicity towards cancer cells. Front Immunol 13:742571. https:\/\/doi.org\/10.3389\/fimmu.2022.742571","journal-title":"Front Immunol"},{"issue":"6","key":"368_CR96","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ni.3443","volume":"17","author":"JS Silver","year":"2016","unstructured":"Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R, Erjefalt JS, Kolbeck R, Humbles AA (2016) Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17(6):626\u2013635. https:\/\/doi.org\/10.1038\/ni.3443","journal-title":"Nat Immunol"},{"issue":"1","key":"368_CR97","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","volume":"46","author":"Y Simoni","year":"2017","unstructured":"Simoni Y, Fehlings M, Kl\u00f8verpris HN, McGovern N, Koo SL, Loh CY, Lim S, Kurioka A, Fergusson JR, Tang CL, Kam MH, Dennis K, Lim TKH, Fui ACY, Hoong CW, Chan JKY, Curotto de Lafaille M, Narayanan S, Baig S et al (2017) Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46(1):148\u2013161. https:\/\/doi.org\/10.1016\/j.immuni.2016.11.005","journal-title":"Immunity"},{"issue":"1","key":"368_CR98","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev-immunol-020711-075053","volume":"30","author":"H Spits","year":"2012","unstructured":"Spits H, Cupedo T (2012) Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Ann Rev Immunol 30(1):647\u2013675. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075053","journal-title":"Ann Rev Immunol"},{"issue":"2","key":"368_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Vivier E (2013) Innate lymphoid cells \u2014 a proposal for uniform nomenclature. Nat Rev Immunol 13(2):145\u2013149. https:\/\/doi.org\/10.1038\/nri3365","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"368_CR100","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.3324\/haematol.2014.119602","volume":"100","author":"S Trabanelli","year":"2015","unstructured":"Trabanelli S, Curti A, Lecciso M, Salome B, Riether C, Ochsenbein A, Romero P, Jandus C (2015) CD127+ innate lymphoid cells are dysregulated in treatment naive acute myeloid leukemia patients at diagnosis. Haematologica 100(7):e257\u2013e260. https:\/\/doi.org\/10.3324\/haematol.2014.119602","journal-title":"Haematologica"},{"issue":"1","key":"368_CR101","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41467-017-00678-2","volume":"8","author":"S Trabanelli","year":"2017","unstructured":"Trabanelli S, Chevalier MF, Martinez-Usatorre A, Gomez-Cadena A, Salom\u00e9 B, Lecciso M, Salvestrini V, Verdeil G, Racle J, Papayannidis C, Morita H, Pizzitola I, Grandcl\u00e9ment C, Bohner P, Bruni E, Girotra M, Pallavi R, Falvo P, Leibundgut EO, Jandus C (2017) Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis. Nat Commun 8(1):593. https:\/\/doi.org\/10.1038\/s41467-017-00678-2","journal-title":"Nat Commun"},{"issue":"2","key":"368_CR102","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1053\/gast.1996.v110.pm8566583","volume":"110","author":"H Tsushima","year":"1996","unstructured":"Tsushima H, Kawata S, Tamura S, Ito N, Shirai Y, Kiso S, Imai Y, Shimomukai H, Nomura Y, Matsuda Y, Matsuzawa Y (1996) High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110(2):375\u2013382. https:\/\/doi.org\/10.1053\/gast.1996.v110.pm8566583","journal-title":"Gastroenterology"},{"issue":"13","key":"368_CR103","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1084\/jem.20130071","volume":"210","author":"JE Turner","year":"2013","unstructured":"Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, Panzer U, Helmby H, Stockinger B (2013) IL-9\u2013mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med 210(13):2951\u20132965. https:\/\/doi.org\/10.1084\/jem.20130071","journal-title":"J Exp Med"},{"issue":"5","key":"368_CR104","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/cas.14374","volume":"111","author":"T Ueda","year":"2020","unstructured":"Ueda T, Kumagai A, Iriguchi S et al (2020) Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer\/innate lymphoid cells. Cancer Sci 111(5):1478\u20131490. https:\/\/doi.org\/10.1111\/cas.14374","journal-title":"Cancer Sci"},{"issue":"4","key":"368_CR105","doi-asserted-by":"publisher","first-page":"OE01","DOI":"10.7860\/JCDR\/2015\/12235.5814","volume":"9","author":"A Valizadeh","year":"2015","unstructured":"Valizadeh A (2015) Role of IL-25 in immunity. J Clin Diagn Res 9(4):OE01\u2013OE04. https:\/\/doi.org\/10.7860\/JCDR\/2015\/12235.5814","journal-title":"J Clin Diagn Res"},{"key":"368_CR106","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3389\/fimmu.2020.01190","volume":"11","author":"R Verma","year":"2020","unstructured":"Verma R, Er JZ, Pu RW, Sheik Mohamed J, Soo RA, Muthiah HM, Tam JKC, Ding JL (2020) Eomes expression defines group 1 innate lymphoid cells during metastasis in human and mouse. Front Immunol 11:1190. https:\/\/doi.org\/10.3389\/fimmu.2020.01190","journal-title":"Front Immunol"},{"issue":"4","key":"368_CR107","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/jid.2013.477","volume":"134","author":"F Villanova","year":"2014","unstructured":"Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, Chapman A, Smith CH, Di Meglio P, Nestle FO (2014) Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134(4):984\u2013991. https:\/\/doi.org\/10.1038\/jid.2013.477","journal-title":"J Invest Dermatol"},{"issue":"10","key":"368_CR108","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41577-021-00595-y","volume":"21","author":"E Vivier","year":"2021","unstructured":"Vivier E (2021) The discovery of innate lymphoid cells. Nat Rev Immunol 21(10):616\u2013616. https:\/\/doi.org\/10.1038\/s41577-021-00595-y","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"368_CR109","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Spits H (2018) Innate lymphoid cells: 10 years on. Cell 174(5):1054\u20131066. https:\/\/doi.org\/10.1016\/j.cell.2018.07.017","journal-title":"Cell"},{"issue":"7585","key":"368_CR110","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature16161","volume":"529","author":"J von Moltke","year":"2016","unstructured":"von Moltke J, Ji M, Liang HE, Locksley RM (2016) Tuft-cell-derived IL-25 regulates an intestinal ILC2\u2013epithelial response circuit. Nature 529(7585):221\u2013225. https:\/\/doi.org\/10.1038\/nature16161","journal-title":"Nature"},{"issue":"5","key":"368_CR111","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.immuni.2010.10.017","volume":"33","author":"C Vonarbourg","year":"2010","unstructured":"Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, H\u00f6lscher C, H\u00f6nig M, Pannicke U, Schwarz K, Ware CF, Finke D, Diefenbach A (2010) Regulated expression of nuclear receptor ROR\u03b3t confers distinct functional fates to NK cell receptor-expressing ROR\u03b3t+ innate lymphocytes. Immunity 33(5):736\u2013751. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.017","journal-title":"Immunity"},{"key":"368_CR112","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2021.01.002","volume":"502","author":"J Wan","year":"2021","unstructured":"Wan J, Wu Y, Huang L, Tian Y, Ji X, Abdelaziz MH, Cai W, Dineshkumar K, Lei Y, Yao S, Sun C, Su Z, Wang S, Xu H (2021) ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Lett 502:34\u201343. https:\/\/doi.org\/10.1016\/j.canlet.2021.01.002","journal-title":"Cancer Lett"},{"issue":"7","key":"368_CR113","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41422-020-0312-y","volume":"30","author":"S Wang","year":"2020","unstructured":"Wang S, Qu Y, Xia P, Chen Y, Zhu X, Zhang J, Wang G, Tian Y, Ying J, Fan Z (2020) Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer. Cell Res 30(7):610\u2013622. https:\/\/doi.org\/10.1038\/s41422-020-0312-y","journal-title":"Cell Res"},{"issue":"4","key":"368_CR114","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","volume":"171","author":"OE Weizman","year":"2017","unstructured":"Weizman OE, Adams NM, Schuster IS, Krishna C, Pritykin Y, Lau C, Degli-Esposti MA, Leslie CS, Sun JC, O\u2019Sullivan TE (2017) ILC1 confer early host protection at initial sites of viral infection. Cell 171(4):795\u2013808.e12. https:\/\/doi.org\/10.1016\/j.cell.2017.09.052","journal-title":"Cell"},{"issue":"11","key":"368_CR115","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni.2133","volume":"12","author":"C Wilhelm","year":"2011","unstructured":"Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, Sparwasser T, Helmby H, Stockinger B (2011) An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12(11):1071\u20131077. https:\/\/doi.org\/10.1038\/ni.2133","journal-title":"Nat Immunol"},{"issue":"1","key":"368_CR116","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","volume":"21","author":"TA Wynn","year":"2003","unstructured":"Wynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21(1):425\u2013456. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.141142","journal-title":"Annu Rev Immunol"},{"key":"368_CR117","doi-asserted-by":"publisher","first-page":"1033904","DOI":"10.3389\/fimmu.2022.1033904","volume":"13","author":"L Xiong","year":"2022","unstructured":"Xiong L, Nutt SL, Seillet C (2022) Innate lymphoid cells: more than just immune cells. Front Immunol 13:1033904. https:\/\/doi.org\/10.3389\/fimmu.2022.1033904","journal-title":"Front Immunol"},{"issue":"12","key":"368_CR118","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.celrep.2015.02.057","volume":"10","author":"W Xu","year":"2015","unstructured":"Xu W, Domingues RG, Fonseca-Pereira D, Ferreira M, Ribeiro H, Lopez-Lastra S, Motomura Y, Moreira-Santos L, Bihl F, Braud V, Kee B, Brady H, Coles MC, Vosshenrich C, Kubo M, Di Santo JP, Veiga-Fernandes H (2015) NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors. Cell Rep 10(12):2043\u20132054. https:\/\/doi.org\/10.1016\/j.celrep.2015.02.057","journal-title":"Cell Rep"},{"issue":"4","key":"368_CR119","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s12094-019-02160-5","volume":"22","author":"X Xuan","year":"2020","unstructured":"Xuan X, Zhou J, Tian Z, Lin Y, Song J, Ruan Z, Ni B, Zhao H, Yang W (2020) ILC3 cells promote the proliferation and invasion of pancreatic cancer cells through IL-22\/AKT signaling. Clin Transl Oncol 22(4):563\u2013575. https:\/\/doi.org\/10.1007\/s12094-019-02160-5","journal-title":"Clin Transl Oncol"},{"issue":"6721","key":"368_CR120","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/17812","volume":"397","author":"Y Yokota","year":"1999","unstructured":"Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, Nishikawa SI, Gruss P (1999) Development of peripheral lymphoid organs and natural killer cells depends on the helix\u2013loop\u2013helix inhibitor Id2. Nature 397(6721):702\u2013706. https:\/\/doi.org\/10.1038\/17812","journal-title":"Nature"},{"key":"368_CR121","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.04406","volume":"3","author":"X Yu","year":"2014","unstructured":"Yu X, Wang Y, Deng M, Li Y, Ruhn KA, Zhang CC, Hooper LV (2014) The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. elife 3:e04406. https:\/\/doi.org\/10.7554\/eLife.04406","journal-title":"elife"},{"issue":"2","key":"368_CR122","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.immuni.2019.01.012","volume":"50","author":"NA Yudanin","year":"2019","unstructured":"Yudanin NA, Schmitz F, Flamar AL, Thome JJC, Tait Wojno E, Moeller JB, Schirmer M, Latorre IJ, Xavier RJ, Farber DL, Monticelli LA, Artis D (2019) Spatial and temporal mapping of human innate lymphoid cells reveals elements of tissue specificity. Immunity 50(2):505\u2013519.e4. https:\/\/doi.org\/10.1016\/j.immuni.2019.01.012","journal-title":"Immunity"},{"issue":"7","key":"368_CR123","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Bi J, Zheng X, Chen Y, Wang H, Wu W, Wang Z, Wu Q, Peng H, Wei H, Sun R, Tian Z (2018) Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat Immunol 19(7):723\u2013732. https:\/\/doi.org\/10.1038\/s41590-018-0132-0","journal-title":"Nat Immunol"}],"container-title":["Interdisciplinary Cancer Research","Cancer Immunology and Genetics: An Interdisciplinary Approach"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/16833_2024_368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T15:24:07Z","timestamp":1753370647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/16833_2024_368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031993732","9783031993749"],"references-count":123,"URL":"https:\/\/doi.org\/10.1007\/16833_2024_368","relation":{},"ISSN":["2731-4561","2731-457X"],"issn-type":[{"type":"print","value":"2731-4561"},{"type":"electronic","value":"2731-457X"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"11 September 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}